Speakers

Michael Beck, MD
Germany
Children’s Hospital at University of Mainz

Brian Bigger, PhD
United Kingdom
The University of Manchester

Melissa Bilodeau
Canada
MPS IVA Patient

Stephanie Bozarth, MSW
United States
Chairman, Board of Directors, National MPS Society

Barbara Burton, MD
United States
Ann & Robert H. Lurie Children’s Hospital of Chicago

Lorne Clarke, MD
Canada
British Columbia Children’s Hospital

Olivier Danos, PhD
United States
CSO, REGENXBIO

Patricia Dickson, MD
United States
Harbor- UCLA Medical Center
Los Angeles Biomedical Research Institute

Deborah Eastwood, MB, ChB, FRCS
United Kingdom

Julie Eisengart, PhD, LP
United States
University of Minnesota

Steven Gray, PhD
United States
University of TX Southwestern Medical Center

Paul Harmatz, MD
United States
Children’s Hospital of Oakland

Sura Hane
Switzerland
MPS VI Patient

Stacy Hewson, MS, MSc, CCGC, CGC
Canada
The Hospital for Sick Children, Toronto

Melissa Hogan
United States
President, Project Alive

Emil Kakkis, MD, PhD
United States
President/CEO, Ultragenyx
EveryLife Foundation

Terri Klein, NPGC
United States
President/CEO, National MPS Society

Tim Miller, PhD
United States
CEO, Abeona Therapeutics

Joseph Muenzer, MD, PhD
United States
The University of North Carolina at Chapel Hill

Paul Orchard, MD
United States
University of Minnesota

Anya Prince, MPP, JD
United States
University of Iowa Law

Mathias Schmidt, PhD
United States
CEO, ArmaGen, Inc.

Elsa Shapiro, PhD, ABPP
United States
University of Minnesota

Bob Stevens
United Kingdom
Group Chief Executive, MPS Society UK

Shunji Tomatsu, MD, PhD
United States
Nemours /Alfred I. duPont Hospital for Children

Raymond Wang, MD
United States
Children’s Hospital of Orange County

Klane White, MD, MS
United States
Seattle Children’s Hospital

Chester Whitley, MD, PhD
United States
University of Minnesota